Brave Haller out for "a few months" after having testicular tumour operation

Borussia Dortmund striker Sebastien Haller is set to be out for a few months due to his testicular tumour, the club have confirmed.

Haller, who joined Dortmund in a £27million move from Ajax earlier this month, had to leave the Bundesliga club's pre-season camp last week after he complained of feeling unwell and the tumour was detected.

His treatment has begun, with Dortmund sporting director Sebastian Kehl revealing they are preparing to be without him for the opening portion of the season. "Sebastien was operated on last week. We asked for patience at the time," he told reporters.

READ MORE: Win 2 tickets to watch England vs Germany in Nations League action at Wembley Stadium

"The therapy is currently being discussed. Sebastien will be out for a few months but once we can be more precise about that we will communicate it."

Haller arrived as the replacement for Manchester City new boy Erling Haaland. Kehl was asked if Dortmund would be making another signing in his absence.

He replied: "We're only going to do something if it really makes sense in the end, and otherwise we'll put our trust in the guys we have here."

Haller completed the first stage of his treatment last week, posting a picture of himself in his hospital bed to social media. He wrote: "Hello everyone, I wanted to let you know that Step 1 has been completed!

"I would like to thank the @BVB (Dortmund) and the medical team who were exceptional with me. A big thank you also to all the nursing staff of the hospital for their support – benevolence."

Dortmund will get their season underway without the Ivory Coast international on Friday (July 29) when they face 1860 Munich in the first round of the German Cup.


  • Neymar to go on trial just weeks before World Cup over alleged corruption

  • West Ham spend all day spelling Gianluca Scamacca – only to suffer announcement blunder

  • Football player, 29, dies after 'massive brawl' on pitch caused by ref's decision

Source: Read Full Article